Hoeller, Sylvia and Walz, Christoph and Reiter, Andreas and Dirnhofer, Stephan and Tzankov, Alexandar. (2011) PCM1-JAK2-fusion : a potential treatment target in myelodysplastic-myeloproliferative and other hemato-lymphoid neoplasms. Expert opinion on therapeutic targets, Vol. 15, H. 1. pp. 53-62.
Full text not available from this repository.
Official URL: http://edoc.unibas.ch/dok/A6006844
Downloads: Statistics Overview
Abstract
Activating mutations of the JAK2 gene are of tumorigenic significance in myeloproliferative neoplasms. Translocations involving the JAK2 locus are of oncogenic importance in acute leukemias, myelodysplastic/myeloproliferative diseases and T-cell lymphomas. JAK2 locus gains, which are recurrent in Hodgkin's- and primary mediastinal B-cell lymphoma, are also efficient mechanisms of JAK2 activation. Recently, specific drugs blocking JAK2 have been developed and are currently in clinical trials.
| Faculties and Departments: | 03 Faculty of Medicine > Bereich Querschnittsfächer (Klinik) > Pathologie USB > Histopathologie (Dirnhofer) 03 Faculty of Medicine > Departement Klinische Forschung > Bereich Querschnittsfächer (Klinik) > Pathologie USB > Histopathologie (Dirnhofer) |
|---|---|
| UniBasel Contributors: | Dirnhofer, Stephan and Tzankov, Alexandar |
| Item Type: | Article, refereed |
| Article Subtype: | Research Article |
| Publisher: | Informa Healthcare |
| ISSN: | 1472-8222 |
| Note: | Publication type according to Uni Basel Research Database: Journal article |
| Related URLs: | |
| Identification Number: |
|
| Last Modified: | 13 Sep 2013 07:59 |
| Deposited On: | 13 Sep 2013 07:57 |
Repository Staff Only: item control page